Newsroom

AposHealth® and Manifest Media’s Game Recognizes Game podcast unite talent and media, to lead a national conversation on MSK recovery, greatness and Apos® NEW YORK,

According to the National Institute of Health (NIH), 16% of people around the world have knee osteoarthritis (OA) — a condition that is among the

We proudly announce that Apos has been recognized as the “Innovation in Knee and Back Pain Treatment Company of the Year – NY” by the

The World Health Organization reports that 365 million people around the world live with knee osteoarthritis (OA). This condition causes chronic pain and can have

By Ganit Segal, MPE, MBA, EVP — Chief Scientific & Innovation Officer of AposHealth According to the World Health Organization (WHO), 365 million people live

The World Health Organization (WHO) reports that over half a billion people in the world are living with osteoarthritis — one of the most common

Knee osteoarthritis (OA) is a common condition that affects a person’s joints, causing chronic pain, but did you know that this condition affects women more

Your Health Magazine’s latest article shines a light on the growing problem of chronic knee pain, now affecting 1 in 4 adults. The piece highlights

In this episode, we sit down with Dr. Nina Cha, Vice President of Clinical Services at AposHealth, to explore the evolving landscape of knee and

In 2023, the World Health Organization (WHO) found that 528 million people were living with osteoarthritis (OA) — a condition that affects the joints and

The award celebrates AposHealth’s flagship solution, Apos®, a precision medicine approach that transforms the management of chronic knee osteoarthritis and lower back pain. The International

According to recent research, 15% of the global population over the age of 30 is affected by osteoarthritis, or OA, the most common form of

A new study published in the Global Spine Journal, one of the most respected journals in spine and orthopedics research, highlights the superior effectiveness of Apos®

AposHealth®, a global leader in non-invasive musculoskeletal treatments, has been honored with the 2025 Global Recognition Award for its groundbreaking innovation in musculoskeletal care. The

AposHealth received the 2024 Global Excellence Award for its innovative, non-surgical knee-pain relief solution, Apos®, which transforms lives and reduces costs NEW YORK, NY, UNITED

The European Alliance of Associations for Rheumatology (EULAR) has updated its guidelines for the non-pharmacological management of hip and knee osteoarthritis (OA) based on an extensive

AposHealth, a leader in non-invasive knee osteoarthritis treatment with its flagship Apos®, has achieved significant recognition, underscoring its commitment to innovative, clinically effective, and cost-saving

Ben Feldman, M.Med.Sc., with his extensive international healthcare background and expertise in performance and brand marketing, will spearhead AposHealth’s efforts to accelerate growth and expand

A recent study published in the Journal of Healthcare Economics Outcomes Research1 highlights the substantial impact of Apos® on healthcare resource utilization (HCRU) in patients

AposHealth®, a global leader in musculoskeletal (MSK) solutions, has been recognized with the award from the Pittsburgh Business Group on Health (PBGH) at the 2023

AposHealth® a disruptive global company focused on revolutionising the treatment of musculoskeletal (MSK) conditions such as knee osteoarthritis (OA) is delighted to announce that its

AposHealth®, a pioneering healthcare technology company specializing in innovative solutions for chronic musculoskeletal pain, is pleased to announce the appointment of Dr. David Shulkin as

A recent study on Apos®, a medical device that treats chronic knee conditions, could have significant implications on the cost, pain, and quality-of-life problems associated

Coverage for AposHealth’s revolutionary non-invasive treatment for knee osteoarthritis is now available to federal agencies including the U.S. Department of Veterans Affairs which serves more

AposHealth®‘s next major advance in our mission to create the best patient-centric orthopedic solutions available has arrived. We’ve reimagined the foot-worn device component of our

AposHealth®, a global leader in the identification and treatment of gait-related conditions, has partnered with TalarMade, a European-based provider of orthotics, podiatry, rehab, and physical

Big news for the future of mobility performance and AposHeath®, as research findings recently published in the journal Gait & Posture demonstrate that OneStep—an innovative,

AposHealth’s flagship solution, Apos®, recently received a significant distinction in Europe in a  Medtech Innovation Briefing (MIB) published by the National Institute for Health and

DANVILLE, Pa. – Geisinger, in partnership with AposHealth, today announced that a new non-invasive, drug-free treatment for patients suffering knee pain from osteoarthritis will be

Rachel Yesharim joins the company’s executive team to help build AposIQ® – a new business unit applying cutting edge technology and data science to inform gait-related treatments.  AposHealth®, a global leader in the

A study that was done in collaboration between Montefiore Medical Center and the Apos Israel research group is already influencing the way medical treatments are measured in clinical practice. The study aimed to develop a questionnaire to assess patients, based on

If you’re a fast walker, you’re likely to live longer. The correlation between walking speed and lifespan has been widely studied and is a good

HealthCare Partners (HCP) today announced an expansion of its partnership with AposHealth® to bring an innovative, non-invasive treatment for knee osteoarthritis currently offered to its

Healthcare company joins Innovate UK’s efforts to address the effects of COVID-19  LONDON, Jan. 04, 2021 (GLOBE NEWSWIRE) — AposHealth®, a global leader in the identification

PITTSBURGH and NEW YORK (Dec. 7, 2020) — Highmark Health, a leading national blended health organization, today announced that it is working with AposTherapy to

AposHealth is thrilled to announce that Dr. David B. Nash is joining our advisory board.   David B. Nash, MD, MBA, is the Founding Dean Emeritus — and remains on the full-time faculty as the

AposHealth President & CEO Dr. Cliff Bleustein, MD, MBA, recently shared his experience and advice related to the process of placing a medical device on